SE7706673L - Forfarande for framstellning av flerfaldigt halogenerade steroider - Google Patents

Forfarande for framstellning av flerfaldigt halogenerade steroider

Info

Publication number
SE7706673L
SE7706673L SE7706673A SE7706673A SE7706673L SE 7706673 L SE7706673 L SE 7706673L SE 7706673 A SE7706673 A SE 7706673A SE 7706673 A SE7706673 A SE 7706673A SE 7706673 L SE7706673 L SE 7706673L
Authority
SE
Sweden
Prior art keywords
alpha
halogenerated
steroids
procedure
chlorine
Prior art date
Application number
SE7706673A
Other languages
Unknown language ( )
English (en)
Other versions
SE436751B (sv
Inventor
J Kalvoda
G Anner
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7706673L publication Critical patent/SE7706673L/sv
Publication of SE436751B publication Critical patent/SE436751B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7706673A 1976-09-29 1977-06-08 Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar SE436751B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (sv) 1976-09-29 1976-09-29

Publications (2)

Publication Number Publication Date
SE7706673L true SE7706673L (sv) 1978-03-30
SE436751B SE436751B (sv) 1985-01-21

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706673A SE436751B (sv) 1976-09-29 1977-06-08 Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar

Country Status (24)

Country Link
JP (1) JPS5356652A (sv)
AT (3) AT363197B (sv)
AU (1) AU514200B2 (sv)
BE (1) BE859120A (sv)
CA (1) CA1101410A (sv)
CH (9) CH624967A5 (sv)
CY (1) CY1178A (sv)
DD (1) DD133150A5 (sv)
DE (1) DE2743069C2 (sv)
DK (1) DK146017C (sv)
ES (1) ES462763A1 (sv)
FR (1) FR2366311A1 (sv)
GB (1) GB1563638A (sv)
HK (1) HK16683A (sv)
HU (1) HU175218B (sv)
IE (1) IE46047B1 (sv)
IL (1) IL53012A (sv)
KE (1) KE3258A (sv)
LU (1) LU75903A1 (sv)
MY (1) MY8400092A (sv)
NL (1) NL7710089A (sv)
SE (1) SE436751B (sv)
SG (1) SG3383G (sv)
ZA (1) ZA775800B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
EP0523132A1 (en) * 1990-03-27 1993-01-20 Schering Corporation PROCESS FOR 9$g(a)-HYDROXY STEROID DEHYDRATION
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
AU2002359523A1 (en) 2001-11-29 2003-06-17 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
JP6997624B2 (ja) 2015-06-18 2022-01-17 ボシュ ヘルス ユーエス,エルエルシー. 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
JPS6214557B2 (sv) 1987-04-02
CH631998A5 (en) 1982-09-15
DK146017C (da) 1983-10-24
HK16683A (en) 1983-05-27
ATA151279A (de) 1980-12-15
LU75903A1 (sv) 1978-05-16
SG3383G (en) 1983-09-09
CH631999A5 (en) 1982-09-15
DK256977A (da) 1978-03-30
CH625810A5 (en) 1981-10-15
CA1101410A (en) 1981-05-19
KE3258A (en) 1983-03-04
SE436751B (sv) 1985-01-21
BE859120A (fr) 1978-03-28
DK146017B (da) 1983-05-24
ES462763A1 (es) 1978-05-16
IL53012A (en) 1982-05-31
IE46047B1 (en) 1983-02-09
CY1178A (en) 1983-06-10
FR2366311B1 (sv) 1982-12-03
DE2743069A1 (de) 1978-03-30
IL53012A0 (en) 1977-11-30
CH632279A5 (en) 1982-09-30
CH625809A5 (en) 1981-10-15
FR2366311A1 (fr) 1978-04-28
AT363197B (de) 1981-07-10
AT363202B (de) 1981-07-27
DE2743069C2 (de) 1987-03-05
HU175218B (hu) 1980-06-28
ATA691077A (de) 1980-12-15
AU514200B2 (en) 1981-01-29
DD133150A5 (de) 1978-12-13
CH632521A5 (en) 1982-10-15
JPS5356652A (en) 1978-05-23
NL7710089A (nl) 1978-03-31
AU2914877A (en) 1979-04-05
ZA775800B (en) 1978-08-30
AT363203B (de) 1981-07-27
CH625808A5 (en) 1981-10-15
IE46047L (en) 1978-03-29
ATA151379A (de) 1980-12-15
CH624967A5 (en) 1981-08-31
GB1563638A (en) 1980-03-26
MY8400092A (en) 1984-12-31
CH632000A5 (en) 1982-09-15

Similar Documents

Publication Publication Date Title
SE7706673L (sv) Forfarande for framstellning av flerfaldigt halogenerade steroider
SE423903B (sv) Forfarande for framstellning av 9 alfa, 21-dihalogen-11 beta,17 alfa-dihydroxi-6 alfa-flour-16 alfa-metyl-pregna-1,4-dien-3,20-dion-estrar
US2813883A (en) 9alpha-halo-17beta-hydroxy-17alpha-methyl-androstane-3, 11-diones
GB1391443A (en) Ester of betamethasone and its 9alpha-chloro analogue
GB1077393A (en) New steroids
GB944716A (en) 10ª -fluoro steroids and their preparation
GB926472A (en) New halogen-pregnenes and a process for their manufacture
GB806045A (en) Steroids
GB923125A (en) Steroid compounds
GB743921A (en) Dehydrohalogenation of -a-halo-keto steroids
GB909614A (en) New cyclopentanophenanthrene derivatives and processes for the production thereof
ES371022A1 (es) Procedimiento para la preparacion de 9 alfa - fluor - 16 - metilen-prednisolona o bien prednisona y sus 21-esteres.
GB744804A (en) Improvements in or relating to the manufacture of acid halides of the vitamin a-series
GB888974A (en) Steroids
GB931577A (en) Improvements in or relating to the manufacture of steroids
GB759745A (en) Steroids
GB803656A (en) Dehydrocortical hormones
GB959793A (en) Improvements in or relating to steroids
GB844319A (en) Preparation of í¸-3-ketosteroids
ES234653A1 (es) PROCEDIMIENTO PARA LA PREPARACIoN DE UN ESTERoIDE
GB716676A (en) Steroids
ES395740A1 (es) Procedimiento para la preparacion de nuevos 6 alfa. 16 alfa-dimetilesteroides.
GB790452A (en) Steroids and the preparation thereof
GB799722A (en) Steroid compounds
GB809493A (en) Improvements in or relating to steroids and the manufacture thereof

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7706673-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7706673-6

Format of ref document f/p: F